Clinical Trials Directory

Trials / Conditions / Bipolar Disorders

Bipolar Disorders

29 registered clinical trials studyying Bipolar Disorders5 currently recruiting.

StatusTrialSponsorPhase
RecruitingRecovery in Telling Life Stories
NCT07082777
University of AarhusN/A
Enrolling By InvitationAssess the Utility of a Speech-based Machine Learning Algorithm to Predict Treatment Response to Psychiatric I
NCT06823024
Psyrin Inc.
Not Yet RecruitingMonPsy&Moi: A Digital Platform for Collecting Patient-Reported Experience and Outcome Measures in Psychiatry
NCT06818227
Assistance Publique Hopitaux De Marseille
Not Yet RecruitingEffects of Lurasidone on Left Ventricle Systolic Functions
NCT06695676
Aydin Adnan Menderes University
RecruitingA Novel Peer-Delivered Recovery-Focused Suicide Prevention Intervention for Veterans With Serious Mental Illne
NCT05537376
VA Office of Research and DevelopmentN/A
CompletedOral and Jaw Health in Bipolar Patients
NCT06034769
Bandırma Onyedi Eylül University
UnknownStudy of the Effectiveness of Specific Training of Health Professionals on Adherence in Bipolar Disorder
NCT02904083
Assistance Publique Hopitaux De MarseilleN/A
CompletedRepresentations and Strategies for Recovery
NCT03028545
Hôpital le VinatierN/A
UnknownCognitive, Morphological and Neurobiological Progressive Aspects in Bipolar Disorders in the Elderly: Toward t
NCT02843906
University Hospital, GrenobleN/A
TerminatedEvaluation of a Serious Game for Patients With Bipolar Disorder Involved in a Psychoeducation Group
NCT02936466
University Hospital, MontpellierN/A
CompletedEnhancing Outcomes, Reducing Costs: Evaluating Peer Support for Mood Disorders
NCT02242669
Massachusetts General Hospital
CompletedEffectiveness of a Physical Activity and Diet Program in Patients With Psychotic Disorder (CapiCor)
NCT01729650
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i GurinaN/A
CompletedPhysical Co-morbidity, Poor Health Behaviour and Health Promotion in Verona Patients With Functional Psychoses
NCT02807688
Azienda ULSS di Verona e ProvinciaN/A
CompletedFunctional Correlates of Bipolar Disorders and Effects of the Psychoeducation. an fMRI Study
NCT01821469
University Hospital, GrenobleN/A
CompletedFeeling of Being in Control of One's Own Action
NCT01312649
University Hospital, Strasbourg, FranceN/A
CompletedThe Purpose of the Study is to Gain an In-depth Picture of the Patient Management and Prescription Behaviours
NCT01377896
AstraZeneca
CompletedStudy of the Clinical Management of Bipolar Disease
NCT01062607
AstraZeneca
UnknownBipolar Disorder With Alcoholism in Han Chinese
NCT01188395
National Cheng-Kung University Hospital
CompletedSeries Studies of Bipolar Disorder-Valproate add-on Memantine
NCT01188148
National Cheng-Kung University HospitalPhase 2 / Phase 3
CompletedA NIS Evaluating the Treatment Patterns of Atypical Antipsychotics in Patients Diagnosed With Bipolar I or II
NCT00888264
AstraZeneca
CompletedOmega-3 Fatty Acids in Bipolar Patients With a Low Omega-3 Index and Reduced Heart Rate Variability
NCT00891826
Ludwig-Maximilians - University of MunichN/A
CompletedMetabolic Effects of Switching to Aripiprazole in Patients With Bipolar Disorders
NCT00845988
Seoul National University HospitalPhase 4
CompletedInjectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI)
NCT00453804
State University of New York - Upstate Medical UniversityPhase 4
CompletedEscitalopram as a Mood Stabilizer for Bipolar II Disorder
NCT00156325
The University of New South WalesPhase 2
TerminatedOpen-label Adjunctive Zonisamide for Bipolar Disorder
NCT00047567
Elan PharmaceuticalsPhase 4
CompletedA Study of the Effectiveness and Safety of Risperidone Compared With Placebo in the Treatment of Manic Episode
NCT00253162
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 3
CompletedA Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic Episodes Assoc
NCT00257075
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 3
CompletedA Study of the Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar Disorder
NCT00240721
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 3
CompletedA Study of the Effectiveness and Safety of Risperidone as add-on Therapy to Mood Stabilizers in the Treatment
NCT00253149
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 3